Roche CIT

A platform provides latest cancer immunotherapy scientific information.

CIT (Cancer ImmunoTherapy) is an application developed by Roche. It contains update cancer immunotherapy scientific information. This platform is intended for the exclusive use by Healthcare Professionals in Taiwan.

It is designed to unsolicited provide scientific updated related to cancer immunotherapy and provide clinical supporting tool related to cancer immunotherapy treatment. It features personalized and interactive design to

facilitate the scientific exchange.